Latest Data & Signals Issued

Below are some of the latest signals issued for Equillium Inc.

General

Signal Type Signal Value Data
Score 2.360 35 days ( -30.32 %
Last Price $2.88 -1.03 %
Performance History
7 Days
$2.77 $2.88
3.97%
30 Days
$2.81 $2.88
2.49%
12 Mos
$0.350 $2.88
723.09%

13/18

Active Buy Signals

Specific Signals

Short Term
Net score: 75.64
Signal Type Signal Value Importance Data
High / Low Buy Very Low $2.84 - $3.10
Position: 15.38% from low / 84.62% from high · Momentum: 20.06%
Trend - 3 mos 57.61 % High Width: 34.98 %
Pred. range - 3 mos $3.92 - $5.30 Low 36.27 % - 83.94 %
Volume Direction Sell High Volume: 1,561,106 · Direction: 0
Pivot Short Sell Very Low Jun 30, 2026 - 9 days
RSI Short Pivot Signal Buy Very Low Jul 10, 2026 - 2 days
Short MA 3 mos Buy Low Jul 07, 2026 - 5 days
Long MA 3 mos Buy Medium May 20, 2026 - 36 days
Short/Long MA 3 mos Buy Medium Apr 21, 2026 - 57 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 66.14
Signal Type Signal Value Importance Data
Trend - 12 mos 141.26 % Very High Width: 64.47 %
Pred. range - 12 mos $4.78 - $7.87 High 66.10 % - 173.18 %
Short MA 12 mos Sell Very High Jul 09, 2026 - 3 days
Long MA 12 mos Sell Very High May 18, 2026 - 38 days
Short/Long MA 12 mos Buy Very High Feb 05, 2026 - 108 days
Pivot Long Sell Low Jun 30, 2026 - 9 days
RSI Long Pivot Signal Buy Low Jul 09, 2026 - 3 days
Bollinger Buy Medium Jun 30, 2026 - 9 days
MACD Buy High No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Click to get the best stock tips daily for free!
ABOUT EQUILLIUM INC.
Equillium
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which is in Phase III clinical trials for the treatment of acute graft-versus-host disease; completed Phase Ib...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
10.58% Jun 29
NMRK
$15.02
0.466% Jun 24
X
XMAX
$8.34
2.40% Jun 24
NESR
$25.07
12.49% Jun 23
CAG
$13.43
6.70% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE